Novo Holdings creates Hemab
Danish Novo Holdings has founded Hemab ApS that is focussed on fighting orphan bleeding disorders by bi-specific antibodies.
Biotech companies launch Biotech Austria
Austria has needed a biotech association for a long time. In just two months, entrepreneurs have launched Biotech Austria.
How microplastic particles get into the body
Weathered microplastic particles may pose a greater risk than pristine ones, suggests a study of German researchers on mouse cells.
Centogene and Anylam launch clinical programme
Diagnostics developer Centogene NV and Alnylam Pharmaceuticals launched a clinical programme aimed at improving ATTRv diagnosis.
Avantium NV bags money for demo plant
Green chemistry company Avantium NV has secured a 7.5m funding from the National Programme Groningen to support the construction of a 5 kilotonnes FDCA plant.
How stress brings cancer to life again
Swiss Noema Pharma raises CHF54m in Series A financing
Noema Pharma AG kicks off with CHF54m and licenced drug candidates from Roche AG.
Germany first EU country to launch COVID-19 therapy offensive?
After months of lobbying by the BIOM biotech cluster, Bavaria is launching a 50m initiative to push the best and fastest COVID-19 therapies.
Moderna to file for EU approval of mRNA-1273 vaccine
COVID-19 mRNA vaccine developer Moderna Inc reported it will file for FDA and EMA authorisation of mRNA-1273 based on Phase III results.
Drug set to rescue COVID-19 patients at ICUs
Aviptadil, a vasodilator originally developed to treat erectile dysfunction, led to a 72% survival in critically-ill COVID-19 patients.